FDA Inspection 1065634 — Amneal Pharmaceuticals of New York, LLC
The FDA completed an inspection of Amneal Pharmaceuticals of New York, LLC on July 10, 2018 in Brookhaven, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 10, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Brookhaven, NY (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)